Advancing New Technologies for Brain- and Neurostimulation

Optoceutics seeks to provide the cutting edge of technology advancements within brain stimulation to patients, enabling better personalized care, and ultimately,

Read more Pre-order here

Investigational use

Optoceutics is currently planning clinical trials on the potential effect of masked 40 Hz light on Alzheimer’s Disease patients.

The device to be used in the trials is considered an Investigational Device and limited by United States law to investigational use.

Sign up for our newsletter to stay up to date on the latest information

Join mailing list

SELECTED PARTNERS

Optoceutics partner
Optoceutics partner
Optoceutics partner
Optoceutics partner
Optoceutics partner
Optoceutics partner
Optoceutics partner
Optoceutics partner

LATEST NEWS

Read more about the team behind the project.

MEET THE TEAM